PanTher Therapeutics
Get verified emails for PanTher Therapeutics employees
About PanTher Therapeutics
|
|
|
1-10 employees
View all
|
|
Biotechnology
|
|
191 Dexter Ave, Watertown, Massachusetts 02472, US
|
|
PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. Our highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatment at the tumor site. This distinctive targeting capability uniquely positions us to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.
|
PanTher Therapeutics Email Format
The widely used PanTher Therapeutics email format is {f}{last}@panthertx.com (e.g. [email protected]), which is used 100% of the time.
| PanTher Therapeutics Email Formats | Example Email Formats | Percentage |
|---|---|---|
| {f}{last} | [email protected] |
100%
|
PanTher Therapeutics Alternatives
Frequently Asked Questions about PanTher Therapeutics
What is PanTher Therapeutics email format?
The widely used PanTher Therapeutics email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.
What is PanTher Therapeutics customer service number?
To contact PanTher Therapeutics customer service number in your country click here to find.
Who is the CEO of PanTher Therapeutics?
Laura Indolfi is the CEO of PanTher Therapeutics. To contact Laura Indolfi email at [email protected].
PanTher Therapeutics Staff Directory
Search PanTher Therapeutics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Search Portal
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
